Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-β

被引:14
|
作者
Puissant-Lubrano, Benedicte [1 ,2 ]
Viala, Frederique
Winterton, Peter [2 ]
Abbal, Michel [1 ,2 ]
Clanet, Michel
Blancher, Antoine [1 ,2 ]
机构
[1] CHU Toulouse, Hop Rangueil, Immunol Lab, F-31059 Toulouse 9, France
[2] Univ Toulouse 3, Fac Med Toulouse Rangueil, Immunogenet Mol Lab, F-31062 Toulouse 4, France
关键词
multiple sclerosis; thymic function; regulatory T cells; IFN-beta treatment; T cell subsets; CD45RC;
D O I
10.1016/j.jneuroim.2007.10.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We explored the parameters of central and peripheral tolerance in patients with stable relapsing-remitting multiple sclerosis, treated or not with IFN-beta TREC-positive T cells were lower in patients compared with controls, mainly in CD4+ subset, compatible with a thymus dysfunction or an expansion of peripheral lymphocytes. Compared to controls, the frequency of activated CD4+CD25+ T cells was higher in patients without modification of the CD4+CD25(high) T cell proportion. The IFN-beta-treatment did not modify the TREC-positive cell frequency nor the naive/memory T cell subset percentage but was associated with lower blood lymphocyte count and a lower frequency of CD4+CD45RC(high) subset. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 50 条
  • [41] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
  • [42] Neurovascular coupling in patients with relapsing-remitting multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 146 : 24 - 28
  • [43] Comorbidity in in patients with relapsing-remitting multiple sclerosis.
    Somilo, O., V
    Makarov, S. O.
    Kalbus, O., I
    MEDICNI PERSPEKTIVI, 2024, 29 (03): : 137 - 143
  • [44] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
    Mendes, M. F.
    Balsimelli, S.
    Tilbery, C. P.
    MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
  • [45] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
  • [46] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
  • [47] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [48] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
    Nocentini, U
    Pasqualetti, P
    Bonavita, S
    Buccafusca, M
    De Caro, MF
    Farina, D
    Girlanda, P
    Le Pira, F
    Lugaresi, A
    Quattrone, A
    Reggio, A
    Salemi, G
    Savettieri, G
    Tedeschi, G
    Trojano, M
    Valentino, P
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
  • [49] Prevalence of Depression in Patients with Relapsing-remitting Multiple Sclerosis
    Iranmanesh, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 523 - 523
  • [50] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Tomaž Omerzu
    Jožef Magdič
    Radovan Hojs
    Uroš Potočnik
    Mario Gorenjak
    Tanja Hojs Fabjan
    Wiener klinische Wochenschrift, 2024, 136 : 40 - 47